FBInvestor
Stocks / Maxcyte Inc
Institutional Ownership

Maxcyte Inc

CUSIP 57777K106COMMXCTQ1 2026

13D / 13G Filings
28
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
14.2%
Max % of class reported
Institutional Holders
126
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

28 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Cadian Capital Management, LP13G/A3.5%3.68MSEC
2Feb 5, 2026Capricorn Fund Managers Ltd13G7.7%8.20MSEC
3Jan 21, 2026Blackrock, Inc.13G/A6.6%7.00MSEC
4Nov 14, 2025Cadian Capital Management, LP13G/A7.7%8.23MSEC
5Nov 4, 2025Mirabella Financial Services LLP13G/A7.7%8.20MSEC
6Nov 3, 2025Mirabella Financial Services LLP13G6.2%6.60MSEC
7Oct 24, 2025River Global Investors LLP13D5.2%SEC
8Feb 13, 2025Cadian Capital Management, LP13G/A8.9%9.34MSEC
9Feb 5, 2025Blackrock, Inc.13G/A7.8%8.26MSEC
10Nov 13, 2024Cadian Capital Management, LP13G/A7.8%8.19MSEC

18 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Maxcyte Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →